Quantitative Health Sciences

Medicine & Life Sciences

1. Neoplasms 100%
2. Population 97%
3. Breast Neoplasms 91%
4. Confidence Intervals 89%
5. Survival 84%
6. Systematic Reviews 81%
7. Meta-Analysis 79%
8. Alzheimer Disease 77%
9. Genes 71%
10. Therapeutics 64%
11. Single Nucleotide Polymorphism 63%
12. Odds Ratio 62%
13. Incidence 55%
14. Mortality 55%
15. Cohort Studies 50%
16. Biomarkers 49%
17. Cognitive Dysfunction 49%
18. Genome-Wide Association Study 46%
19. Mutation 45%
20. Electronic Health Records 42%
21. Genome 41%
22. Colorectal Neoplasms 41%
23. Ovarian Neoplasms 40%
24. Clinical Trials 39%
25. Rheumatoid Arthritis 39%
26. Dementia 37%
27. Prostatic Neoplasms 37%
28. Epidemiology 36%
29. Case-Control Studies 35%
30. Randomized Controlled Trials 35%
31. Guidelines 35%
32. Heart Failure 34%
33. Health 34%
34. Pancreatic Neoplasms 32%
35. Physicians 32%
36. Alleles 31%
37. Amyloid 30%
38. Drug Therapy 30%
39. Quality of Life 30%
40. Databases 30%
41. Delivery of Health Care 30%
42. Lung Neoplasms 30%
43. Recurrence 28%
44. Costs and Cost Analysis 28%
45. Tendons 28%
46. Non-Hodgkin's Lymphoma 27%
47. Phenotype 26%
48. Genotype 26%
49. Logistic Models 25%
50. Irritable Bowel Syndrome 24%
51. Colonic Neoplasms 24%
52. Placebos 24%
53. Atrial Fibrillation 24%
54. Datasets 24%
55. Body Mass Index 24%
56. B-Cell Chronic Lymphocytic Leukemia 24%
57. Kidney 23%
58. Proteins 23%
59. Myocardial Infarction 22%
60. Radiotherapy 21%
61. Hospitalization 21%
62. Hospital Emergency Service 21%
63. Pharmacogenetics 21%
64. Elderly 21%
65. Breast Density 21%
66. Stroke 21%
67. Child 21%
68. Transplants 20%
69. Progression-Free Survival 20%
70. Smoking 20%
71. Adenocarcinoma 20%
72. Exercise 20%
73. Genetic Variation 20%
74. Serum 20%
75. Cardiovascular Diseases 20%
76. Practice Guidelines 19%
77. Pharmaceutical Preparations 19%
78. Brain 19%
79. Medical Records 19%
80. Obesity 19%
81. Shared Decision Making 18%
82. Breast 18%
83. Biopsy 18%
84. Registries 18%
85. Comorbidity 18%
86. Depression 18%
87. Genomics 18%
88. Research Personnel 18%
89. Ovarian Epithelial Carcinoma 18%
90. African Americans 17%
91. DNA 17%
92. Safety 17%
93. Education 17%
94. Prospective Studies 16%
95. Atrophy 16%
96. Non-Small Cell Lung Carcinoma 16%
97. Primary Health Care 16%
98. Blood Pressure 16%
99. Statistics 16%